Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorcyclizine HCl Alone or with Ribavirin in Chronic Hepatitis C
NCT02118012Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chlorcyclizine in hepatitis C (HCV), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Mar 2014; status: completed.
02
Drugs
chlorcyclizine
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02118012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118012.